Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maki Baba
Long-Term Outcome of Immunosuppressive Therapy for Japanese Patients With Lower-Risk Myelodysplastic Syndromes
International Journal of Hematology
Hematology
Related publications
Long-Term Outcome of Anemic Lower-Risk Myelodysplastic Syndromes Without 5q Deletion Refractory to or Relapsing After Erythropoiesis-Stimulating Agents
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Romiplostim Monotherapy in Thrombocytopenic Patients With Myelodysplastic Syndromes: Long-Term Safety and Efficacy
British Journal of Haematology
Hematology
Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Androgen Therapy for Patients With Lower-Risk Myelodysplastic Syndrome and Significant Cytopenia: A Retrospective Study
British Journal of Haematology
Hematology
Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
Mayo Clinic Proceedings
Medicine
Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes
Cancer Control
Medicine
Oncology
Hematology
Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes
Haematologica
Hematology
Deferasirox Therapy Is Associated With Reduced Mortality Risk in a Medicare Population With Myelodysplastic Syndromes
Journal of Comparative Effectiveness Research
Health Policy
